매출 성장 + 마진 확대 + FCF 양수
Positive매출이 +28.5% 성장하면서 영업이익률이 -6.4%에서 4.5%로 확대되었다. FCF도 양수를 유지하여 질적 성장이 확인된다.
Evidence
매출 YoY +28.5%영업이익률 -6.4%→4.5%FCF 169
Inspire Medical Systems
INSP · New York Stock Exchange$63.08+1.51%
2026-09-04 closeInspire Medical Systems last closed at $63.08 (+1.51%) on 2026-09-04. Signals today: MA aligned. Listed on New York Stock Exchange; price, financials and dividends update daily after market close.
Loading chart…
CloseMA20MA60MA120
New high + volume — the real recordrecord · not a prediction
Last 30 sessions
277 picks
Next-day win rate
44.2%
Avg next-day
-0.28%
vs market
-0.51%p
Every new-high-plus-volume pick we actually published (US market) — not this stock alone.
Signal history
| Date | Signal | +20 trading days |
|---|---|---|
A record, not a prediction.
How this is calculated
"·" means fewer than 20 trading days have passed since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.
Trade plan
Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.
A calculator · not advice or a guarantee
Financials & valuation at a glance
B+
Overall: 건강관리 267/745 · top 36%
Factor composite · relative position in sector
PER 34.25 · PBR 2.66 — own-history percentile 100/100 · 100/100
Open self-history band
PER100/100
PBR100/100
Factual information · not investment advice
Past reported results · not investment advice
More — deeper indicators
Financial safety
Reference indicatorAs of 2024Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 9.63
Distress
Grey
Safe
- Altman Z''
- 9.63
- Beneish M-Score
- -2.56
- Sloan accrual
- -9.49%
No statistical flag
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Why has this company moved this way?
Auditable observations with the original numeric evidence.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
8/9Strong
Piotroski measures year-over-year financial improvement, not absolute quality.
Financial improvement score8/9
Profitability
- Positive ROAPass
- Positive OCFPass
- Improving ΔROAPass
- Accruals (OCF > net income)Pass
Leverage & liquidity
- Lower debtPass
- Higher current ratioNot passed
- No new sharesPass
Efficiency
- Higher gross marginPass
- Higher asset turnoverPass
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Industry structure
USAs of 2026-09-05건강관리
This stock is in 건강관리: revenue rank 138 of 543, share 0%.
138 / 5430%revenue share
Who dominates this industry?
- 1CVS Health14.1%
- 2McKesson13.6%
- 3Cigna9.4%
- 4Cardinal Health8.4%
- 5Centene6.2%
- 6Inspire Medical Systems0%
Concentration
DistributedCR3 37.1%HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.
Polarization
Winner-take-all deepeningConsistentPolarization measures industry gaps and structure, not valuation, forecast, or investment advice.
Margin lens
- IQR%p
- 159.97
- Direction
- 축소
- Level
- 넓음
- Years
- 21
Value lens
- P90/P10
- 24.4
- Median P/B
- 3.02
- Level
- 넓음
- n
- 463
Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)
Factual information, not investment advice.
Risk sensitivity — adverse assumptions
Metric changes under stated assumptions; not a forecast or investment advice.
Base metrics
- Operating margin
- 4.5%
- Interest coverage
- 1,640.1x
- Return on equity (ROE)
- 7.8%
Operating margin −5pp
Operating lossInterest coverageBase 1,640.1x adverse case -184.4x
Return on equity (ROE)Base 7.8% adverse case -0.6%
Revenue −15%
TolerableInterest coverageBase 1,640.1x adverse case 1,394.1x
Return on equity (ROE)Base 7.8% adverse case 4.4%
Interest rate +2pp
TolerableInterest coverageBase 1,640.1x adverse case 15.1x
Return on equity (ROE)Base 7.8% adverse case 4.9%
Interest coverage limit
Current margin 4.5ppInterest coverage limit at an operating margin of 0%
Interest expense coverage threshold
Connections
AI-extracted related companies · for reference
Customers
Hospitals & sleep clinicsENT physiciansInsurers
Competitors
Same theme
FDASleep apnea
Recent filings
Filings for overseas stocks are on the way. For now we cover Korean stocks only.
About Inspire Medical Systems
- What technical signals does Inspire Medical Systems (INSP) have?
- Inspire Medical Systems current technical signals: MA alignment (score 0.76).
- Is Inspire Medical Systems a cup-and-handle pattern?
- No. Inspire Medical Systems has no valid cup-and-handle signal right now.
- What are Inspire Medical Systems's financials and valuation?
- Inspire Medical Systems's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Quantus Signal · live data · not investment advice · Privacy Policy